- Home
- XBIO
as 07-26-2024 4:00pm EST
Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing immune-oncology technologies addressing cancers. The company is also engaged in progressing XCART, a personalized CAR T platform technology. The Company's DNase platform is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which have been implicated in cancer progression and resistance to cancer treatments. The company also has oncology therapeutic investigational drug candidate XBIO-101 for the treatment of progestin-resistant endometrial cancer.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | FRAMINGHAM |
| Market Cap: | 6.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 9.5K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.93 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.87 - $5.97 | Next Earning Date: | 08-09-2024 |
| Revenue: | $2,444,959 | Revenue Growth: | 27.09% |
| Revenue Growth (this year): | -11.65% | Revenue Growth (next year): | -18.18% |
Latest Xenetic Biosciences Inc. News
XBIO Breaking Stock News: Dive into XBIO Ticker-Specific Updates for Smart Investing
GOBankingRates
2 months ago
5 Reasons a Biden Second Term Could Be a Financial Disaster for Boomers
AFP
2 months ago
Bumrah delivers as India beat Pakistan in low-scoring thriller
AFP
2 months ago
Italy beat Bosnia in final Euros warm-up
Bloomberg
2 months ago
Macron Calls French Legislative Election After Far-Right Surge
AFP
2 months ago
Trump loyalists proud to support 'felon' at Las Vegas rally
Business Insider
2 months ago
US solar producers could finally have a fighting chance as tariffs kick in on cheaper imports from Asia
Insider Monkey
2 months ago
The Best Woody Perfume For Women
Reuters
2 months ago
Microsoft unveils all-digital Xbox consoles, 'Doom' title at Games Showcase
Compare XBIO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "XBIO Xenetic Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.